Thyrocare Technologies Ltd
NSE:THYROCARE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
IN |
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
|
A
|
Air Products and Chemicals Inc
BMV:APD
|
US |
|
S
|
SD Standard ETC PLC
OSE:SDSD
|
CY |
|
L
|
LegalZoom.com Inc
NASDAQ:LZ
|
US |
Wall St Price Targets
THYROCARE Price Targets Summary
Thyrocare Technologies Ltd
According to Wall Street analysts, the average 1-year price target for THYROCARE is 600.78 INR with a low forecast of 540.35 INR and a high forecast of 672 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is THYROCARE's stock price target?
Price Target
600.78
INR
According to Wall Street analysts, the average 1-year price target for THYROCARE is 600.78 INR with a low forecast of 540.35 INR and a high forecast of 672 INR.
What is the Revenue forecast for Thyrocare Technologies Ltd?
Projected CAGR
18%
Over the last 9 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 4 years is 18%.
What is the Operating Income forecast for Thyrocare Technologies Ltd?
Projected CAGR
30%
Over the last 9 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 4 years is 30%.
What is the Net Income forecast for Thyrocare Technologies Ltd?
Projected CAGR
34%
Over the last 9 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 4 years is 34%.
